Optimization of the Time and Dosage of Trametinib in BRAF Negative Juvenile Patients
Clinical trial NCT04943224 · RECRUITING
Trial details
- NCT number
- NCT04943224
- Sponsor
- Anna Raciborska
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-01
- Primary completion
- 2027-06-30
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.